Discovery of Thieno[3,2-<i>b</i>]pyridine-5-carboxamide and 2,3-Difluorobenzamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5

This Letter describes the discovery of novel mGlu<sub>5</sub> NAMs <b>VU6031545</b> and <b>VU6024945</b>. Starting from previously reported picolinamide compounds, a structure-activity relationship study of various core isosteres was conducted, leading to the identification of thieno[3,2-<i>b</i>]pyridine-5-carboxamide and 2,3-difluorobenzamide as competent core replacements. These compounds are highly potent as well as brain penetrant with an IVIVC agreement and improved oral bioavailability in rats.

Authors

Institutions

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2025-04-22
DOI
https://doi.org/10.1021/acsmedchemlett.5c00119
Citations
2
Primary Topic
Neuroscience and Neuropharmacology Research
Type
article
Field-Weighted Citation Impact
1.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery of Thieno[3,2-b]pyridine-5-carboxamide and 2,3-Difluorobenzamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5

Aaron M. Bender, Alice L. Rodriguez, Natasha B. Billard, Changho Han et al.
2 citations
ACS Medicinal Chemistry Letters
Neuroscience and Neuropharmacology Research
1.82
article

Discovery of Thieno[3,2-b]pyridine-5-carboxamide and 2,3-Difluorobenzamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5

Aaron M. Bender, Alice L. Rodriguez, Natasha B. Billard, Changho Han, David Whomble, Kayla J. Temple, Katherine J. Watson, Scott H. Henderson, Hyekyung P. Cho, P. Jeffrey Conn, Andrew S. Felts, Katherine E. Crocker, Colleen M. Niswender, Jordan C. O’Neill, Craig W. Lindsley, Jerri M. Rook, Anna L. Blobaum, Rory A. Capstick, Olivier G. Boutaud, Julie L. Engers, Mallory A. Maurer, Sichen Chang, Weimin Peng
article en
2 citations

Abstract

This Letter describes the discovery of novel mGlu<sub>5</sub> NAMs <b>VU6031545</b> and <b>VU6024945</b>. Starting from previously reported picolinamide compounds, a structure-activity relationship study of various core isosteres was conducted, leading to the identification of thieno[3,2-<i>b</i>]pyridine-5-carboxamide and 2,3-difluorobenzamide as competent core replacements. These compounds are highly potent as well as brain penetrant with an IVIVC agreement and improved oral bioavailability in rats.

ACS Medicinal Chemistry LettersVol. 16(5)
Allen Institute for Brain Science (US), Vanderbilt University (US), Center for Discovery (US)
William K. Warren Foundation, National Institutes of Health
Openalex Percentile: Top 16%
Neuroscience and Neuropharmacology Research
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.